Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...He said its products complied with the EU’s “extremely strict” production standards and that its factories were comparable “to the Pfizers of the world”....
...Soriot’s new pay deal comes after the company hit a $45bn sales target in 2023 that the chief executive had set in 2014 when the company fended off a takeover bid from US rival Pfizer....
...GSK has sued Pfizer and BioNTech, alleging that their pharmaceutical rivals’ Covid-19 vaccine infringed “revolutionary” mRNA patents the British company filed in 2010....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
...Emblaveo, marketed in Europe by US pharmaceutical company Pfizer, combines two existing medicines to tackle so-called Gram-negative bacteria that are among the leading drug-resistance threats....
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
...In response to these concerns, Pfizer initiated a significant cost-cutting programme, worth at least $4bn....
...wants a pivot in the biotech’s sales strategy for its Covid-19 shot, which is based on traditional vaccine technology, to target older people unnerved by rare side effects associated with mRNA jabs from Pfizer...
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...He now hopes to bring a case to trial alleging that the product — sold by GSK, Sanofi, Pfizer and Boehringer Ingelheim over many years, caused his disease....
...GSK secured approval for Arexvy from the US Food and Drug Administration at the start of May, almost a month before Pfizer’s Abrysvo....
...Shares in consumer pharmaceutical group Haleon rose 8 per cent on Thursday after it forecast stronger than anticipated sales for 2024 and announced share buybacks worth £500mn....
...Partners have included Pfizer and Eli Lilly and it generated Rmb16.1bn ($2.2bn) in revenues last year from the 20 largest names and earned Rmb26bn — about two-thirds of its revenues — from the US, which...
...Germany’s BioNTech, which developed its own mRNA-based Covid vaccine with Pfizer, has also scaled back its African ambitions but has broken ground on a vaccine manufacturing site in Rwanda....
...Share moves to note on the New York Stock Exchange include Vertex Pharmaceuticals, Apple and Pfizer: Apple gained 1.7 per cent to a record high close of $197.96 a share....
...Strong vaccine sales powered British pharmaceutical company GSK to higher than expected earnings in 2023, as the company’s new RSV jab gained “blockbuster” status just over six months after its US launch...
...Since it was spun off from pharmaceutical giant GSK in 2022, the London-listed company has taken steps to streamline its business with a restructuring programme and job cuts, together with the disposal of...
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...There have been large investments in vaccine delivery systems in recent years, such as the mRNA technology used for the BioNTech/Pfizer and Moderna Covid-19 vaccines....
International Edition